Towards Healthcare
Genome Editing Market
Updated Date: 01 November 2025   |   Report Code: 5161
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Genome Editing Market 2025 Growth Boosted by CRISPR/Cas9 (44% Share) and Ex-Vivo Delivery (52% Share)

According to market projections, the genome editing sector is expected to grow from USD 9.39 billion in 2024 to USD 44.95 billion by 2034, reflecting a CAGR of 16.95%. Applications in various industries promote the growth of the genome editing market.

Last Updated : 01 November 2025 Category: Biotechnology Insight Code: 5161 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Genome Editing Market Assessment

  • Overview
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

North America Genome Editing Market Assessment

  • Overview
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Europe Genome Editing Market Assessment

  • Overview
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Asia Pacific Genome Editing Market Assessment

  • Overview
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Latin America Genome Editing Market Assessment

  • Overview
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

MEA Genome Editing Market Assessment

  • Overview
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Company Profiles

  • Thermo Fisher Scientific, Inc
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Lonza
  • Bluebird Bio, Inc.
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Genscript Biotech Corp
  • Transposagen Biopharmaceuticals, Inc.
  • Danaher Corporation
  • Horizon Discovery Ltd. (Revvity, Inc.)
  • Takara Bio Inc.
  • AstraZeneca
  • Cellectis S.A.
  • Caribou Biosciences, Inc
  • Intellia Therapeutics, Inc.
  • CRISPR Therapeutics
  • Precision BioSciences
  • Editas Medicine
  • Sangamo Therapeutics
  • Recombinetics
  • Cibus Inc.
  • Merck KGaA

Conclusion & Recommendations

FAQ's

Answer : Genetically engineered animal models of CVD have been made possible thanks to the development of CRISPR-based germline genome editing techniques. CRISPR-based gene editing techniques are quicker, simpler to use, and more widely applicable than traditional gene targeting methods that utilize embryonic stem cells.

Answer : In an effort to treat sickness or strengthen the body resistance to illness, gene therapy attempts to correct a damaged gene or replace it with a healthy one. Numerous illnesses, including cancer, AIDS, diabetes, heart disease, cystic fibrosis, and hemophilia, may benefit from it as a treatment.

Answer : World Health Organization, National Heart, Lung, and Blood Institute, FDA, The White House, USAD, Press Information Bureau.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar